Cytovale raises $100m in funding to expand reach of sepsis test
IntelliSep is reportedly the only US Food and Drug Administration (FDA)-cleared cellular host diagnostic for use in emergency departments.
IntelliSep is reportedly the only US Food and Drug Administration (FDA)-cleared cellular host diagnostic for use in emergency departments.
The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Mendaera and EchoNous ink deal to combine robotics and ultrasound
Owkin and AstraZeneca to develop AI tool for breast cancer testing
Perimeter completes enrolment for AI-assisted breast imaging trial
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule